LAWRENCEVILLE, N.J., March 24, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that the U ...

Australian-US biotech Opthea Ltd has reported disappointing phase 3 results with its lead drug ... are "no anomalies […] that would cause the board to adopt an alternative view" of its prospects.

The I-20 project is in phase 3, meaning drivers are closer than ever ... Traffic is currently traveling on newly constructed inside lanes. The left lanes are all brand new between Hamilton ...

The contract for the first phase, which was for asbestos abatement and demolition inside the building, also came in at roughly $1.3 million ... Law Library Resources Board will also remain ...